News

2

Jul, 2020

New paper published in WHO Bulletin

Tags:

Our collaborator Prof. Mike Sharland, together with GARDP and St. George’s, University of London researchers have just published a new paper in the WHO Bulletin investigating international antibiotic sales data of child-appropriate oral formulations of antibiotics, with a focus on dispersible tablets.

READ MORE

1

Jul, 2020

ODYSSEY (Penta 20) trial plays an important role in the FDA approval of dolutegravir for children – a big step towards timely access to optimal ART for children

Tags: ,

Data from the ongoing P1093 and ODYSSEY (PENTA20) studies have led to the successful approval of ViiV Healthcare’s submission to the U.S. Food and Drug Administration (FDA) of the adult formulation for children weighing ≥20kg and dolutegravir (DTG) dispersible tablets for children of 4 weeks of age and older.

READ MORE
NEWSLETTER

We would like to update you on our recent activities